Stay updated on PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial
Sign up to get notified when there's something new on the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page.

Latest updates to the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays Revision: v3.6.4 in place of Revision: v3.6.3, indicating a software version update. This change affects internal metadata rather than the public content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe revision label changed from v3.6.2 to v3.6.3, indicating a platform or content management update rather than a modification to study details. No substantive study content appears to be altered.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows an updated revision tag (from v3.6.0 to v3.6.2), indicating an underlying update to the page template or backend while leaving trial information and user actions unchanged.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a new revision label (Revision: v3.6.0); removed the 'Intervention / Treatment' heading and the older revision label (Revision: v3.5.5).SummaryDifference0.6%

- Check62 days agoChange DetectedThe page's revision tag was updated to v3.5.5, replacing the previous v3.5.4. This indicates a small update to the page's metadata or rendering and does not affect trial details.SummaryDifference0.1%

- Check83 days agoChange DetectedA new revision tag v3.5.4 is now shown, replacing the previous v3.5.3. This appears to be an internal site update rather than a modification to the study details or eligibility information on the page.SummaryDifference0.1%

Stay in the know with updates to PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page.